India,United States : Marksans Pharma wins USFDA's approval for Metformin Hydrochloride ER tablets.
Marksans Pharma has won approval from the USFDA for Metformin Hydrochloride extended-release (ER) tablets.
The company said the USFDA has approved an Abbreviated New Drug Application (ANDA) for Metformin Hydrochloride extended-release tablets USP 500 mg and 750 mg.
It said,"Metformin Hydrochloride ER tablets USP 500 mg and 750 mg is therapeutically equivalent to the reference listed drug Glucophage XR extended-release tablets 500mg and 750mg respectively of Bristol Myers Squibb (BMS). Metformin Hydrochloride ER tablets are oral anti-hyperglycemic drugs indicated as an adjunct to diet and exercise to improve glycemic control in patients with type-2 diabetes."
The product's annual sale is around USD 230 million.
[c] 2016 Al Bawaba (Albawaba.com) Provided by SyndiGate Media Inc. ( Syndigate.info ).
|Printer friendly Cite/link Email Feedback|
|Date:||May 4, 2016|
|Previous Article:||Luxembourg : EUROFINS SCIENTIFIC plans EAC acquisition.|
|Next Article:||Malaysia : SUNGAI UDANG faces major decline in prawn catch due to Bridge Development.|